Innovations, challenges, and minimal information for standardization of humanized mice
Open Access
- 24 June 2020
- journal article
- review article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 12 (7) , e8662
Abstract
Mice xenotransplanted with human cells and/or expressing human gene products (also known as “humanized mice”) recapitulate the human evolutionary specialization and diversity of genotypic and phenotypic traits. These models can provide a relevant in vivo context for understanding of human‐specific physiology and pathologies. Humanized mice have advanced toward mainstream preclinical models and are now at the forefront of biomedical research. Here, we considered innovations and challenges regarding the reconstitution of human immunity and human tissues, modeling of human infections and cancer, and the use of humanized mice for testing drugs or regenerative therapy products. As the number of publications exploring different facets of humanized mouse models has steadily increased in past years, it is becoming evident that standardized reporting is needed in the field. Therefore, an international community‐driven resource called “Minimal Information for Standardization of Humanized Mice” (MISHUM) has been created for the purpose of enhancing rigor and reproducibility of studies in the field. Within MISHUM, we propose comprehensive guidelines for reporting critical information generated using humanized mice.Keywords
Funding Information
- Deutsches Zentrum für Infektionsforschung (TTU 07.815)
- Else Kroener Fresenius Stiftung (2017 T04)
- NIH Office of the Director (R24 ODO26440)
- National Cancer Institute (CA031496)
- National Cancer Institute (U01 CA224013)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK104218)
- National Institute of Allergy and Infectious Diseases (AI32963)
This publication has 114 references indexed in Scilit:
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- In Vivo Suppression of HIV by Antigen Specific T Cells Derived from Engineered Hematopoietic Stem CellsPLOS Pathogens, 2012
- Epstein-Barr Virus: An Important Vaccine Target for Cancer PreventionScience Translational Medicine, 2011
- A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver DiseaseGastroenterology, 2011
- Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized miceBlood, 2011
- The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functionalBiochemical and Biophysical Research Communications, 2011
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivoNature Biotechnology, 2010
- Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatmentJournal of Clinical Investigation, 2010
- Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal modelProceedings of the National Academy of Sciences, 2007
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007